患者报告的生活质量：Docetaxel 与 177Lu-617-PSMA 在 #mCRPC 中的对比：加拿大癌症试验组 PR21 试验结果。由 @DKhalafMD 报告。#ESMO26 书面报道由 @zklaassen_md 撰写 > https://bit.ly/4iDewfC #ProstateCancer #ClinicalTrials @myESMO
246 浏览 · 3 赞 · 2 转发 · 0 回复
BNT324-03: A phase 3, randomized, open-label trial comparing elfetabart drozuntecan, a B7H3 antibody-drug conjugate, with investigator's choice of docetaxel or cabazitaxel in patients with metastatic castration-resistant prostate cancer
https://esmocongress.esmo.orgAnbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.org- **标题 / Title：** Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)
https://esmocongress.esmo.org来源：UroToday.com · x.com